Intercept Pharmaceuticals (ICPT) in Focus: Stock Moves 8.6% Higher
Intercept Pharmaceuticals, Inc. ICPT was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $87.4 – $118.7 in the past one-month time frame, witnessed a sharp increase on Friday.
The company has seen one estimate revisions over the past one month versus no revision in the opposite direction, and the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Intercept Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Intercept Pharmaceuticals, Inc. Price and Consensus
Intercept Pharmaceuticals, Inc. Price and Consensus | Intercept Pharmaceuticals, Inc. Quote
A better ranked stock in the Medical - Biomedical and Genetics industry is Alexion Pharmaceuticals, Inc. ALXN which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is ICPT going up? Or down? Predict to see what others think: Up or Down
New Report: An Investor’s Guide to Cybersecurity
Cyberattacks have become more frequent and destructive than ever. In fact, they’re expected to cause $6 trillion per year in damage by 2020.
The cybersecurity industry is expanding quickly in response to these threats. In fact, a projected $170 billion per year will be spent to protect consumer and corporate assets. Zacks has just released Cybersecurity: An Investor’s Guide to Locking Down Profits which reveals 4 promising investment candidates.
Download the new report now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Alexion Pharmaceuticals, Inc. (ALXN) : Free Stock Analysis Report
Intercept Pharmaceuticals, Inc. (ICPT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
